Technetium 99m, as a tracer in nuclear medicine procedures

dc.contributor.author	Ζησιμόπουλος, Αθανάσιος Σ.	el
dc.contributor.author	Κυριατζής, Γ.	el
dc.contributor.author	Μπαμπάτσικου, Φωτούλα Π.	el
dc.contributor.author	Ψύλλας, Δημήτρης	el
dc.contributor.author	Καραθάνος, Ευάγγελος	el
dc.date.accessioned	2015-04-24T08:55:06Z
dc.date.issued	2015-04-24
dc.identifier.uri	http://hdl.handle.net/11400/8833
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	http://pharmakonpress.gr/	en
dc.source	http://www.scopus.com	en
dc.subject	Pharmacokinetics
dc.subject	Φαρμακοκινητική
dc.subject	ιχνηθέτης
dc.subject	Tracer
dc.title	Technetium 99m, as a tracer in nuclear medicine procedures	en
heal.type	journalArticle
heal.classification	Ιατρική
heal.classification	Πυρηνική ιατρική
heal.classification	Medicine
heal.classification	Nuclear medicine
heal.classificationURI	N/A-Ιατρική
heal.classificationURI	N/A-Πυρηνική ιατρική
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh85093011
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh00006940
heal.contributorName	Κουτής, Χαρίλαος	el
heal.dateAvailable	10000-01-01
heal.language	en
heal.access	forever
heal.publicationDate	2009
heal.bibliographicCitation	Zisimopoulos, A., Kyriatzis, G., Babatsikou, F., Psyllas, D., Karathanos, E., et. al. (2009). Technetium 99m, as a tracer in nuclear medicine procedures. "Review of Clinical Pharmacology and Pharmacokinetics International Edition". [online] 23(3): p.171-176. Available from: http://www.scopus.com [Accessed 21/04/2015]	en
heal.abstract	Technetium 99m is a metastable artificial radioisotope used as a radiotracer with advanced and plenty applications in Nuclear Medicine. It is the decay product (daughter element) of Mo-99 following beta decay with half life of 6.03 hours in its metastable state. It has properly physical and chemical characteristics and thus plays a lead role in radiopharmaceutical industry. Under appropriate conditions such as oxidation number, pH, hydrophilic characteristics can produce multiple stable complexes applicative to participate in almost any physical or metabolic pathways to identify a disease or pathological conditions.	el
heal.journalName	Review of Clinical Pharmacology and Pharmacokinetics International Edition	el
heal.journalType	peer-reviewed
heal.fullTextAvailability	false